On Tuesday, Novartis AG ADR (NYSE: NVS) opened higher 1.36% from the last session, before settling in for the closing price of $97.77. Price fluctuations for NVS have ranged from $92.35 to $120.92 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 0.78%. Company’s average yearly earnings per share was noted 17.09% at the time writing. With a float of $1.96 billion, this company’s outstanding shares have now reached $2.00 billion.
Considering the fact that the conglomerate employs 76057 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 74.43%, operating margin of 27.93%, and the pretax margin is 25.89%.
Novartis AG ADR (NVS) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Novartis AG ADR is 0.00%, while institutional ownership is 6.77%. The most recent insider transaction that took place on Aug 12 ’24, was worth 733,572.
Novartis AG ADR (NVS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.83 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.65% during the next five years compared to 5.63% growth over the previous five years of trading.
Novartis AG ADR (NYSE: NVS) Trading Performance Indicators
Check out the current performance indicators for Novartis AG ADR (NVS). In the past quarter, the stock posted a quick ratio of 0.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.99. Likewise, its price to free cash flow for the trailing twelve months is 13.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 8.57, a number that is poised to hit 1.83 in the next quarter and is forecasted to reach 8.21 in one year’s time.
Technical Analysis of Novartis AG ADR (NVS)
Compared to the last year’s volume of 1.33 million, its volume of 1.19 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 11.44%. Additionally, its Average True Range was 1.26.
During the past 100 days, Novartis AG ADR’s (NVS) raw stochastic average was set at 6.07%, which indicates a significant decrease from 17.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.16% in the past 14 days, which was higher than the 15.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $107.51, while its 200-day Moving Average is $106.48. Nevertheless, the first resistance level for the watch stands at $99.74 in the near term. At $100.38, the stock is likely to face the second major resistance level. The third major resistance level sits at $101.08. If the price goes on to break the first support level at $98.39, it is likely to go to the next support level at $97.69. Should the price break the second support level, the third support level stands at $97.05.
Novartis AG ADR (NYSE: NVS) Key Stats
There are currently 2,044,000K shares outstanding in the company with a market cap of 193.89 billion. Presently, the company’s annual sales total 46,660 M according to its annual income of 14,850 M. Last quarter, the company’s sales amounted to 13,172 M and its income totaled 3,189 M.
